NCT06775275 2025-01-15A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLCThe First Affiliated Hospital of Guangzhou Medical UniversityPhase 2 Recruiting60 enrolled